ATS/Alveolar Capillary Dysplasia (ACDMPV) Research Grant


Descriptions

Opportunity type:

Grant

Sponsor:

American Thoracic Society

Award amount and duration:

$100,000 for one year

Currency:

USD

Eligibility

Type:
Faculty

Eligibility - All Grants

The following eligibility requirements apply to all grants unless otherwise specified.

Applicants must:

  • be an ATS member at the time of application OR have at least one key personnel who is an ATS member to submit a letter of intent
  • be an ATS member when the grant is awarded
  • have completed their primary research training (PhD or sub-specialty fellowship) by January 1, 2025
  • have a firm commitment from their home institution for a faculty position by the time the grant is awarded (January 2026)
  • have not received two ATS Research Program grants or be a current ATS Research Program grantee

 

Eligibility - Early-Career Investigators

Applicants must be early-career investigators for all ATS Research Program grants unless otherwise stated.

ATS defines early-career investigators as:

  • Within 0-10 years of terminal degree (e.g. MD, PhD) or completing postdoctoral training, if applicable. For the current grant cycle, this means that you must have received your terminal degree or completed postdoctoral training no earlier than 2015.
     
    • For MDs, postdoctoral training includes clinical sub-specialty training, but not research training. For example, if you are an MD in a fellowship or residency, the eligibility window opens when you have completed the clinical training portion. The eligibility window is not inclusive of research training. To be eligible, you must be 0-10 years from your terminal degree or the end of your clinical sub-specialty training.
    • For PhDs, this definition is inclusive of postdoctoral training.
  • never having received a non-mentored grant ≥ $100,000 per year for at least 2 years.
    • For example, researchers are generally no longer considered early career if they have secured an independent, non-mentored research grant (e.g. R01).

ATS considers exceptions to the early-stage investigator requirement for extenuating circumstances such as parental or military leave. Note that sub-specialty training is not considered an extenuating circumstance.

If you have extenuating circumstances not related to sub-specialty training contact us at researchprogram@thoracic.org before beginning a letter of intent or application.

International Applicants

The ATS defines international applicants as individuals not working at a US-based institution OR someone who does not reside or work in the United States.

ATS accepts submissions from international researchers unless otherwise specified. Review partner grant requirements, which may differ from ATS unrestricted and diversity grants.


ATS Policy on Grant Funding from Other Sources

Simultaneous submission of grants with scientific overlap to other funding agencies is allowed.

However, if multiple grants are funded, then the applicant must notify the Research Program within one month of formal award notification. A Scientific Grant Review Committee subcommittee will assess the degree of overlap. In the case of significant scientific overlap, the applicant will have to choose between the ATS research grant and the other grant.

Budgetary overlap is not allowed. 

Applicants holding active career development grants (e.g. K award) are eligible to receive ATS funding, but the projects must be scientifically distinct. 

Applicants with K99/R00 awards are eligible only if they are within the K99 phase of the award and the project is scientifically distinct.

Summary

Target Audience: Investigators at any stage of their academic career interested in ACDMPV research.

This grant will support research in alveolar capillary dysplasia with misalignment of the pulmonary veins (ACDMPV). Proposals shall have a high likelihood of advancing the understanding of ACDMPV through basic, translational, or clinical research. Priority will be given to projects focused on the potential treatment of ACDMPV, rather than cause, early detection, or diagnosis. Procedures or proposed therapeutic trials may be new, based on recent biochemical or pharmacological evidence, or in preliminary stages of clinical investigation.

Applicants may request up to $100,000 for one year for salaries or supplies or a combination thereof.

Indirect costs will not be paid to the sponsoring institution.

Co-funded by the ACDA and The David Ashwell Foundation.

The ACDA and The David Ashwell Foundation are respectively USA- and UK-based not for profit charitable organizations founded by parents of infants with ACDMPV. Funds are raised by parents, families, and friends globally with the aim of increasing scientific knowledge about ACDMPV and therapeutic strategies related thereto.

Apply for the ATS/Alveolar Capillary Dysplasia (ACDMPV) Research Grant.

Overhead

Indirect costs are not supported for this grant. 


Deadlines

Application deadlines

RSO detailed review deadline

Date:
June 17, 2025 - 12:00 PM

RSO final internal review deadline

Date:
June 26, 2025 - 12:00 PM

Program application deadline

Date:
July 1, 2025 - 9:59 PM

Approvals

NOTE: Consult your Faculty Associate Dean (Research) (ADR) regarding Faculty-specific deadlines and submission processes.

Principal Investigators: Complete a Research Management System (RMS) record, including a copy of your complete application, and submit this for approvals in RMS.

Postdocs, students, and trainees: For fellowships and externally-sponsored research training awards or opportunities, you must complete the Research Funding Application Approval (RFAA) Trainee PDF form, and submit it, along with a complete copy of the application, to Research Services at rsotrainee@ucalgary.ca. Trainees should not use RMS at this time.

Approvals: The University of Calgary requires that all funding applications be approved prior to submission. Approval requires signatures via either RMS or the RFAA Trainee form, in the following order:

  • Principal Investigator
  • Department Head
  • Faculty ADR/Dean
  • Research Services (on behalf of the Vice-President Research)

Read the Meaning of Grant Signatures policy to understand what your approval means. Please see the agency guidelines for details about which signatures are required on your application, as it may differ from internal requirements.

Late submissions: Late submissions will only be accepted in cases of medical or family emergencies, or other exceptional circumstances. If you submit your RMS record to Research Services after the internal deadline has passed, you must secure additional approvals. Please read: Late Applications Process.


Additional Information

Additional Resources

Using RMS:

RMS: Creating a Pre-Award LOI

RMS: Creating a Pre-Award Application

Support for projects involving Indigenous Research:

Support with the development of your grant application is available internally through the Indigenous Research Support Team (IRST). Applicants can reach out by email to IRST at IRST@ucalgary.ca in advance of the RSO internal deadline. For more information about IRST, please visit the IRST webpage.

Support for Knowledge Engagement:

Support for knowledge mobilization/engagement/translation is available internally through the Knowledge to Impact Team. Applicants can reach out by email to the KTI team at knowledge.impact@ucalgary.ca in advance of the RSO internal deadline. For more information, please visit the KTI team webpage.

Support for Research Data Management:

For information on research data management plans, processes, or best practices for your research program, please contact research.data@libanswers.ucalgary.com and/or visit https://libguides.ucalgary.ca/researchdatamanagement.

Support for EDI in Research:

RSO can provide resources and support to research teams on the integration of equitable and inclusive practices in research design and research practice. Contact Erin.OToole@ucalgary.ca for more information.


Contact Details


Keywords

ACDMPV research
treatment of ACDMPV
therapeutic trials